Archshiny Biotechnology Company Limited
Update:2024/12/24
Industries
Main Industry
Consumer Goods
Main Product/Service
Development of AI Software for Medical Imaging
Using our proprietary AI technology, we perform automatic segmentation of various types of brain tumors (such as acoustic neuroma, meningioma, and brain metastasis) on preoperative MRI scans, providing object
Using our proprietary AI technology, we perform automatic segmentation of various types of brain tumors (such as acoustic neuroma, meningioma, and brain metastasis) on preoperative MRI scans, providing object
Founded Year
2018
Unified Business No.
42997421
Status
Active
Number of Employees
1
Total Paid-in
Capital
15,700,000 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
AItewan BioMedical Technology Inc. was founded by Distinguished Professor Wu Yu-Te of National Yang Ming Chiao Tung University (NYCU), following the execution of two National Science and Technology Council (NSTC) Taiwan Germination Program I and II. These